Symbols

CON

Concentra Group·NYSE

--(--)

CON fundamentals

CON Q4 2025 Earnings

Concentra Group (CON) released its earnings on Feb 26, 2026: revenue was 539.10M (YoY +15.93%), beat estimates; EPS was 0.28 (YoY +64.71%), beat estimates.

Revenue / YoY

539.10M

+15.93%

EPS / YoY

0.28

+64.71%

Report date

Feb 26, 2026

CON Earnings Call Summary for Q4,2025

Revenue Growth Accelerates: Q4 2025 revenue up 15.9% YoY to $539.1M, driven by 9% visit growth and 3.1% rate increase.
Profitability Improves: Adjusted EBITDA margin expands to 17.7% (vs 16.7% prior year), with free cash flow conversion at 114%.
Strategic Expansion: 7 de novo sites opened in 2025, targeting 7-9 in 2026 with 3-year payback. Onsite clinics grow 14.6% organically.
New York Opportunity: State fee schedule reforms could unlock dozens of new locations if rates rise sufficiently in 2027.
2026 Outlook: Guided for $2.25B-$2.35B revenue, $450M-$470M EBITDA, with 3x leverage target by year-end.

Earnings

EPS

Revenue

Revenue & Expenses

CON has released its 2025 Q4 earnings report, with revenue of 539.08M, reflecting a YoY change of 15.92%, and net profit of 36.19M, showing a YoY change of 58.73%. The Sankey diagram below clearly presents CON's revenue sources and cost distribution.

Key Indicators

Concentra Group (CON) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Concentra Group (CON)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Concentra Group (CON)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Concentra Group (CON)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown